Cover Image
市場調查報告書

全球胰島素給藥設備市場:簡化的胰島素幫浦及低價胰島素筆針推動市場的成長

Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers

出版商 GBI Research 商品編碼 299030
出版日期 內容資訊 英文 121 Pages
訂單完成後即時交付
價格
Back to Top
全球胰島素給藥設備市場:簡化的胰島素幫浦及低價胰島素筆針推動市場的成長 Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers
出版日期: 2014年04月30日 內容資訊: 英文 121 Pages
簡介

全球胰島素給藥裝置的市場規模預測將從2012年的88億美金,到2019年達到138億美金。此外這段期間的年平均成長率(CAGR)推計將為7%。先進國家(美國、歐洲等)胰島素幫浦接受度擴大、人工胰臟裝置等開發、普及是市場成長的推動要素。同時新興國家市場因為糖尿病的得病率上升及給藥裝置普及率低,也都是推動市場成長的要素。近年來人工胰臟裝置的開發等相關企業正在發展合作。今後先進國家在最新裝置、技術普及的同時,一般認為新興國家(中國、印度等)胰島素筆等傳統型、低價裝置也將日益普及。

本報告提供全球的胰島素給藥設備(胰島素注射用設備)的市場相關分析,提供設備的特徵·定義和最新趨勢,主要的促進·阻礙因素,全球及主要國家的市場趨勢(過去的實際成果值和今後的預測值),再加上主要企業簡介(產業概要·已上市產品),現在正在開發的開發中產品的概要,近來的資本交易·產業重組的動向等調查,並將結果概述為以下內容。

第1章 目錄

第2章 簡介

第3章 糖尿病:疾病概要

第4章 糖尿病:流行病學

第5章 胰島素給藥設備概要

  • 胰島素筆針(再利用型/拋棄式型,針頭)
  • 胰島素幫浦(傳統式/拋棄式型)
  • 胰島素注射器
  • 傳統式胰島素幫浦的配件
  • 胰島素給藥設備比較

第6章 市場特徵

  • 市場收益額的實際成果值(過去8年份)
  • 市場收益額的預測值(今後8年份)
  • 主要企業的市場佔有率(全球,各地區)
  • 市場主要趨勢
    • 全自動式人工胰臟設備的開發上,各企業的動向
    • 產業聯盟促進產品的開發
    • 速效性吸入胰島素:人工胰臟設備利用的研究
  • 市場動態
    • 推動市場要素
    • 阻礙市場要素

第7章 各部門的市場分析與預測

  • 胰島素筆針:收益額的實際成果值(過去8年份)
  • 胰島素筆針:收益額的預測值(今後8年份)
  • 胰島素幫浦:收益額的實際成果值(過去8年份)
  • 胰島素幫浦:收益額的預測值(今後8年份)
  • 胰島素注射器:收益額的實際成果值(過去8年份)
  • 胰島素注射器:收益額的預測值(今後8年份)
  • 傳統胰島素幫浦的配件:收益額的實際成果值(過去8年份)
  • 傳統胰島素幫浦的配件:收益額的預測值(今後8年份)

第8章 各國市場分析與預測

  • 跨國分析
  • 各國的市場趨勢(以金額·數量為準,總計15年份)
    • 美國
    • 日本
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 加拿大
    • 中國
    • 澳洲
    • 印度
    • 巴西

第9章 醫療費給付制度

  • 美國
  • 歐洲各國(全11個國家)
  • 亞太地區各國

第10章 競爭環境

  • 有代表性的胰島素幫浦比較:尺寸·色彩的選擇
  • 有代表性的胰島素幫浦比較:Basal數量/Bolus數量的規格
  • 有代表性的胰島素幫浦比較:Bolus數量計算功能選擇和操作法
  • Novo Nordisk(Novo A/S的子公司)
  • Sanofi
  • Eli Lilly
  • Medtronic
  • Becton, Dickinson and Company
  • Animas
  • F. Hoffmann-La Roche
  • Insulet
  • Asante Solutions
  • Abbott Laboratories
  • Ypsomed
  • Owen Mumford
  • Bioject Medical Technologies
  • Injex - Equidyne Systems
  • Antares Pharma
  • Tandem Diabetes Care
  • Tonghua Dongbao Pharmaceutical
  • Shanghai Fosun Pharmaceutical

第11章 產品平台分析

  • 開發中產品的一覽
    • 胰島素幫浦
    • 胰島素筆針
  • 主要的開發中產品簡介(全36產品)

第12章 產業重組的動向

  • 資本交易的摘要(過去10年份)
  • 主要的資本交易(過去5年份,全7件)

第13章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Summary

GBI Research's report, "Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers" examines the market, competitive landscape, and trends for the four insulin delivery devices market segments: insulin pens, insulin pumps, insulin syringes and traditional insulin pump accessories. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics. The report also reviews the competitive landscape, analyzes each segment's pipeline products and gives details of important mergers and acquisitions. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Scope

  • The markets of 12 key geographies are covered: US, Canada, UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil.
  • Information on market size for the four insulin delivery devices market segments: insulin pens, insulin pumps, insulin syringes and traditional insulin pump accessories.
  • Annual market revenue data forecast to 2019 and company share data for 2012.
  • Qualitative analysis of key trends in the insulin delivery devices market.
  • Information on the competitive landscape and the leading technologies of key players: Novo Nordisk, Medtronic, Sanofi, Eli Lilly, Becton, Dickinson and Company, Animas, Insulet, F. Hoffmann-La Roche, Abbott Laboratories.
  • Information on reimbursement trends and market access for key countries.

Reasons to buy

  • Develop business strategies by understanding the trends and developments driving the global insulin delivery devices market.
  • Design and enhance your product development, marketing, and sales strategies.
  • Exploit merger and acquisition opportunities by identifying the market players with the most innovative pipelines.
  • Develop market-entry and market-expansion strategies.
  • Identify the key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying the products most likely to ensure a robust return.
  • Identify, understand and capitalize on the next big thing in the insulin delivery devices market landscape.
  • Make more informed business decisions from insightful and in-depth analysis of the global insulin delivery devices market and the factors shaping it.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

3. Diabetes - Disease Overview

  • 3.1. Types of Diabetes
    • 3.1.1. Type 1 Diabetes
    • 3.1.2. Type 2 Diabetes
    • 3.1.3. Gestational Diabetes
    • 3.1.4. Signs and Symptoms
    • 3.1.5. Diabetes Diagnosis

4. Diabetes - Epidemiology

5. Global Insulin Delivery Devices Market: Device Overview

  • 5.1. Insulin Pen
    • 5.1.1. Reusable Pen
    • 5.1.2. Disposable Pen
    • 5.1.3. Pen Needle
  • 5.2. Insulin Pump
    • 5.2.1. Traditional Insulin Pump
    • 5.2.2. Disposable Insulin Pump
  • 5.3. Insulin Syringe
  • 5.4. Traditional Insulin Pump Accessories
  • 5.5. Comparison of Insulin Delivery Devices

6. Global Insulin Delivery Devices Market: Market Characterization

  • 6.1. Global Insulin Delivery Devices Market, Revenue ($bn), 2005-2012
  • 6.2. Global Insulin Delivery Devices Market, Revenue, 2012-2019
  • 6.3. Insulin Delivery Devices Market, Global, Key Company Shares, 2012
    • 6.3.1. Global
    • 6.3.2. North America
    • 6.3.3. Europe
    • 6.3.4. Asia-Pacific
  • 6.4. Insulin Delivery Devices Market, Key Trends
    • 6.4.1. Companies Move Closer to Developing Fully Automated Artificial Pancreas System
    • 6.4.2. Collaborations Foster Innovation in Insulin Delivery Devices Market
    • 6.4.3. Inhaled Rapid-Acting Insulin Studied in Research of Artificial Pancreas System
  • 6.5. Market Dynamics
    • 6.5.1. Market Drivers
    • 6.5.2. Market Restraints

7. Global Insulin Delivery Devices Market: Segment Analysis and Forecasts

  • 7.1. Insulin Pens Market, Global, Revenue, 2005-2012
  • 7.2. Insulin Pens Market, Global, Revenue, 2012-2019
  • 7.3. Insulin Pumps Market, Global, Revenue, 2005-2012
  • 7.4. Insulin Pumps Market, Global, Revenue, 2012-2019
  • 7.5. Insulin Syringes Market, Global, Revenue, 2005-2012
  • 7.6. Insulin Syringes Market, Global, Revenue, 2012-2019
  • 7.7. Traditional Insulin Pump Accessories Market, Global, Revenue, 2005-2012
  • 7.8. Traditional Insulin Pump Accessories Market, Global, Revenue, 2012-2019

8. Global Insulin Delivery Devices Market: Country Analysis and Forecasts

  • 8.1. Insulin Delivery Devices Market: Cross-country Analysis
  • 8.2. Historic and Forecast Revenue and Volume, by Country
    • 8.2.1. Insulin Delivery Devices Market, US, Revenue and Volume, 2005-2019
    • 8.2.2. Insulin Delivery Devices Market, Japan, Revenue and Volume, 2005-2019
    • 8.2.3. Insulin Delivery Devices Market, Germany, Revenue and Volume, 2005-2019
    • 8.2.4. Insulin Delivery Devices Market, France, Revenue, 2005-2012
    • 8.2.5. Insulin Delivery Devices Market, UK, Revenue and Volume, 2005-2019
    • 8.2.6. Insulin Delivery Devices Market, Spain, Revenue, Volume, 2005-2019
    • 8.2.7. Insulin Delivery Devices Market, Italy, Revenue, Volume, 2005-2019
    • 8.2.8. Insulin Delivery Devices Market, Canada, Revenue, Volume, 2005-2019
    • 8.2.9. Insulin Delivery Devices Market, China, Revenue, Volume, 2005-2019
    • 8.2.10. Insulin Delivery Devices Market, Australia, Revenue, Volume, 2005-2019
    • 8.2.11. Insulin Delivery Devices Market, India, Revenue, 2005-2012
    • 8.2.12. Insulin Delivery Devices Market, Brazil, Revenue, 2005-2019

9. Global Insulin Delivery Devices Market: Reimbursement System

  • 9.1. US
  • 9.2. Europe
    • 9.2.1. Germany
    • 9.2.2. France
    • 9.2.3. Italy
    • 9.2.4. Spain
    • 9.2.5. UK
    • 9.2.6. Denmark
    • 9.2.7. Norway
    • 9.2.8. Sweden
    • 9.2.9. Belgium
    • 9.2.10. Netherlands
    • 9.2.11. Luxembourg
  • 9.3. Asia-Pacific

10. Global Insulin Delivery Devices Market: Competitive Landscape

  • 10.1. Comparison of Leading Insulin Pumps by Size and Color Options, 2014
  • 10.2. Comparison of Leading Insulin Pumps by Basal and Bolus Specifications, 2014
  • 10.3. Comparison of Leading Insulin Pumps by Bolus Calculator Options and Operation, 2014
  • 10.4. Novo Nordisk (Subsidiary of Novo A/S)
    • 10.4.1. Business Overview
    • 10.4.2. Marketed Products
  • 10.5. Sanofi
    • 10.5.1. Business Overview
    • 10.5.2. Marketed Products
  • 10.6. Eli Lilly
    • 10.6.1. Business Overview
    • 10.6.2. Marketed Products
  • 10.7. Medtronic
    • 10.7.1. Business Overview
    • 10.7.2. Marketed Products
  • 10.8. Becton, Dickinson and Company
    • 10.8.1. Business Overview
    • 10.8.2. Marketed Products
  • 10.9. Animas
    • 10.9.1. Business Overview
    • 10.9.2. Marketed Products
  • 10.10. F. Hoffmann-La Roche
    • 10.10.1. Business Overview
    • 10.10.2. Marketed Products
  • 10.11. Insulet
    • 10.11.1. Business Overview
    • 10.11.2. Marketed Products
  • 10.12. Asante Solutions
    • 10.12.1. Business Overview
  • 10.13. Abbott Laboratories
    • 10.13.1. Business Overview
    • 10.13.2. Marketed Products
  • 10.14. Ypsomed
    • 10.14.1. Business Overview
    • 10.14.2. Marketed Products
  • 10.15. Owen Mumford
    • 10.15.1. Business Overview
    • 10.15.2. Marketed Products
  • 10.16. Bioject Medical Technologies
    • 10.16.1. Business Overview
    • 10.16.2. Marketed Products
  • 10.17. Injex - Equidyne Systems
    • 10.17.1. Business Overview
    • 10.17.2. Marketed Products
  • 10.18. Antares Pharma
    • 10.18.1. Business Overview
    • 10.18.2. Marketed Products
  • 10.19. Tandem Diabetes Care
    • 10.19.1. Business Overview
    • 10.19.2. Marketed Products
  • 10.20. Tonghua Dongbao Pharmaceutical
    • 10.20.1. Business Overview
    • 10.20.2. Marketed Products
  • 10.21. Shanghai Fosun Pharmaceutical
    • 10.21.1. Business Overview
    • 10.21.2. Marketed Products

11. Global Insulin Delivery Devices Market: Product Pipeline Analysis

  • 11.1. Insulin Delivery Devices Market: List of Pipeline Products
    • 11.1.1. Insulin Pumps, List of Pipeline Products
    • 11.1.2. Insulin Pens, List of Pipeline Products
  • 11.2. Insulin Delivery Devices Market: Profiles of Key Pipeline Products
    • 11.2.1. 5th Generation CGM Sensor with t:slim Insulin Delivery System
    • 11.2.2. Accu-Chek Insight
    • 11.2.3. Angel Touch
    • 11.2.4. Animas Vibe Insulin Pump and CGM System
    • 11.2.5. Bolus Patch
    • 11.2.6. Cellnovo Wireless Insulin Pump System
    • 11.2.7. Freehand Patch Pump
    • 11.2.8. Insulin Pump
    • 11.2.9. InsuPatch Device
    • 11.2.10. Integrated CGM with Next Gen OmniPod System PDM
    • 11.2.11. Jewel Pump
    • 11.2.12. La Fenice E
    • 11.2.13. La Fenice V
    • 11.2.14. Lanzi
    • 11.2.15. Mini Pump
    • 11.2.16. MiniMed 640G
    • 11.2.17. MinIn
    • 11.2.18. OmniPod Insulin Pump - New Version
    • 11.2.19. Onetouch Ping Verio Insulin Pump with Meter Remote
    • 11.2.20. OneTouch with Next Gen Omnipod
    • 11.2.21. Patch Pump-1
    • 11.2.22. Patch Pump-2
    • 11.2.23. Patch Pump-3
    • 11.2.24. Spring Insulin Pump
    • 11.2.25. Spring Zone Hybrid Patch Pump
    • 11.2.26. U-Strip Insulin Patch
    • 11.2.27. Exenatide Once Weekly Pen Device
    • 11.2.28. Fix-Flex Device
    • 11.2.29. G-Pen
    • 11.2.30. G-Pen Mini
    • 11.2.31. Insulin Guard Self-Injector Safety Needle
    • 11.2.32. JuniorSTAR
    • 11.2.33. La Fenice Pen
    • 11.2.34. Levemir FlexTouch
    • 11.2.35. Next Generation Pen Needle II
    • 11.2.36. NovoLog FlexTouch

12. Global Insulin Delivery Devices Market: Consolidation Landscape

  • 12.1. Deals Summary (2004-2013)
  • 12.2. Key Deals (2009-2013)
    • 12.2.1. LifeScan Acquires Calibra Medical
    • 12.2.2. Roche Holding Acquires Medingo from Elron Electronic Industries, 2010
    • 12.2.3. Insulet Enters into Co-Development Agreement with Eli Lilly, 2013
    • 12.2.4. Tandem Diabetes Enters into Co-Development Agreement with Juvenile Diabetes Research Foundation for Dual-Chamber Infusion Pump, 2013
    • 12.2.5. Juvenile Diabetes Research Foundation Extends Co-Development Agreement with Becton, Dickinson, 2012
    • 12.2.6. Bioton and SciGen Amend Distribution Agreement with Bayer HealthCare, 2012
    • 12.2.7. Insulet Expands Distribution Agreement with Ypsomed Holding, 2012

13. Appendix

  • 13.1. Definitions
    • 13.1.1. Insulin Delivery
  • 13.2. Abbreviations
  • 13.3. Bibliography
  • 13.4. Research Methodology
    • 13.4.1. Secondary Research
    • 13.4.2. Primary Research
    • 13.4.3. Models
    • 13.4.4. Forecasts
    • 13.4.5. Expert Panel
  • 13.5. Contact Us
  • 13.6. Disclaimer

List of Tables

  • Table 1: Insulin Delivery Devices Market, Global, Diabetes National Prevalence (%) and Patient Population (million), 2013
  • Table 2: Insulin Delivery Devices Market, Global, Revenue ($bn), 2005-2012
  • Table 3: Insulin Delivery Devices Market, Global, Revenue ($bn), 2012-2019
  • Table 4: Insulin Delivery Devices Market, Global, Key Company Share by Region (%), 2012
  • Table 5: Insulin Delivery Devices Market, Number of Patients in 10 Largest Markets (Aged 29-79 Years), 2013-2035
  • Table 6: Insulin Delivery Devices Market, Health Expenditure due to Diabetes (20-79 Years) and Diabetes Population, 2013
  • Table 7: Insulin Pens Market, Global, Revenue ($bn), 2005-2012
  • Table 8: Insulin Pens Market, Global, Revenue Forecast ($bn), 2012-2019
  • Table 9: Insulin Pumps Market, Global, Revenue ($m), 2005-2012
  • Table 10: Insulin Pumps Market, Global, Revenue ($m), 2012-2019
  • Table 11: Insulin Syringes Market, Global, Revenue ($m), 2005-2012
  • Table 12: Insulin Syringes Market, Global, Revenue Forecast ($m), 2012-2019
  • Table 13: Traditional Insulin Pump Accessories Market, Global, Revenue ($m), 2005-2012
  • Table 14: Traditional Insulin Pump Accessories Market, Global, Revenue Forecast ($m), 2012-2019
  • Table 15: Insulin Delivery Devices Market, Global, Cross-country Analysis, CAGR (%), 2005-2019
  • Table 16: Insulin Delivery Devices Market, US, Revenue ($bn), Volume (million), 2005-2012
  • Table 17: Insulin Delivery Devices Market, US, Revenue ($bn), Volume (million), 2012-2019
  • Table 18: Insulin Delivery Devices Market, Japan, Revenue ($m), Volume ('000), 2005-2012
  • Table 19: Insulin Delivery Devices Market, Japan, Revenue ($m), Volume ('000), 2012-2019
  • Table 20: Insulin Delivery Devices Market, Germany, Revenue ($m), Volume ('000), 2005-2012
  • Table 21: Insulin Delivery Devices Market, Germany, Revenue ($m), Volume ('000), 2012-2019
  • Table 22: Insulin Delivery Devices Market, France, Revenue ($m), Volume ('000), 2005-2012
  • Table 23: Insulin Delivery Devices Market, France, Revenue ($m), Volume ('000), 2012-2019
  • Table 24: Insulin Delivery Devices Market, UK, Revenue ($m), Volume ('000), 2005-2012
  • Table 25: Insulin Delivery Devices Market, UK, Revenue ($m), Volume ('000), 2012-2019
  • Table 26: Insulin Delivery Devices Market, Spain, Revenue ($m), Volume ('000), 2005-2012
  • Table 27: Insulin Delivery Devices Market, Spain, Revenue ($m), Volume ('000), 2012-2019
  • Table 28: Insulin Delivery Devices Market, Italy, Revenue ($m), Volume ('000), 2005-2012
  • Table 29: Insulin Delivery Devices Market, Italy, Revenue ($m), Volume ('000), 2012-2019
  • Table 30: Insulin Delivery Devices Market, Canada, Revenue ($m), Volume ('000), 2005-2012
  • Table 31: Insulin Delivery Devices Market, Canada, Revenue ($m), Volume ('000), 2012-2019
  • Table 32: Insulin Delivery Devices Market, China, Revenue ($m), Volume ('000), 2005-2012
  • Table 33: Insulin Delivery Devices Market, China, Revenue ($m), Volume ('000), 2012-2019
  • Table 34: Insulin Delivery Devices Market, Australia, Revenue ($m), Volume ('000), 2005-2012
  • Table 35: Insulin Delivery Devices Market, Australia, Revenue ($m), Volume ('000), 2012-2019
  • Table 36: Insulin Delivery Devices Market, India, Revenue ($m), Volume ('000), 2005-2012
  • Table 37: Insulin Delivery Devices Market, India, Revenue ($m), Volume ('000), 2012-2019
  • Table 38: Insulin Delivery Devices Market, Brazil, Revenue ($m), Volume ('000), 2005-2012
  • Table 39: Insulin Delivery Devices Market, Brazil, Revenue ($m), Volume ('000), 2012-2019
  • Table 40: Novo Nordisk, Key Marketed Products, 2013
  • Table 41: Sanofi, Key Marketed Products, 2013
  • Table 42: Eli Lilly, Key Marketed Products, 2013
  • Table 43: Medtronic, Key Marketed Products, 2013
  • Table 44: Becton, Dickinson and Company, Key Marketed Products, 2013
  • Table 45: Animas, Key Marketed Products, 2013
  • Table 46: F. Hoffmann-La Roche, Key Marketed Products, 2013
  • Table 47: Insulet, Key Marketed Products, 2013
  • Table 48: Asante Solutions, Key Marketed Products, 2013
  • Table 49: Abbott Laboratories, Key Marketed Products, 2013
  • Table 50: Ypsomed Holding AG, Key Marketed Products, 2013
  • Table 51: Owen Mumford, Key Marketed Products, 2014
  • Table 52: Bioject Medical Technologies, Key Marketed Products, 2014
  • Table 53: INJEX - Equidyne Systems, Key Marketed Products, 2014
  • Table 54: Antares Pharma, Key Marketed Products, 2014
  • Table 55: Tandem Diabetes Care, Key Marketed Products, 2014
  • Table 56: Tonghua Dongbao Pharmaceutical, Key Marketed Products, 2014
  • Table 57: Shanghai Fosun Pharmaceutical, Key Marketed Products, 2014
  • Table 58: Insulin Pumps Market, Global, List of Pipeline Products, 2014
  • Table 59: Insulin Pens Market, Global, List of Pipeline Products, 2014
  • Table 60: 5th Generation CGM Sensor With t:slim Insulin Delivery System, Product Status, 2014
  • Table 61: Accu-Chek Insight, Product Status, 2014
  • Table 62: Angel Touch, Product Status, 2014
  • Table 63: Animas Vibe Insulin Pump and CGM System, Product Status, 2014
  • Table 64: Bolus Patch, Product Status, 2014
  • Table 65: Cellnovo Wireless Insulin Pump System, Product Status, 2014
  • Table 66: Freehand Patch Pump, Product Status, 2014
  • Table 67: Insulin Pump, Product Status, 2014
  • Table 68: InsuPatch Device, Product Status, 2014
  • Table 69: Integrated CGM With Next Gen OmniPod System PDM, Product Status, 2014
  • Table 70: Jewel Pump, Product Status, 2014
  • Table 71: La Fenice E, Product Status, 2014
  • Table 72: La Fenice V, Product Status, 2014
  • Table 73: Lanzi, Product Status, 2014
  • Table 74: Mini Pump, Product Status, 2014
  • Table 75: MiniMed 640G, Product Status, 2014
  • Table 76: MinIn, Product Status, 2014
  • Table 77: OmniPod Insulin Pump - New Version, Product Status, 2014
  • Table 78: Onetouch Ping Verio Insulin Pump with Meter Remote, Product Status, 2014
  • Table 79: OneTouch with Next Gen Omnipod, Product Status, 2014
  • Table 80: Patch Pump-1, Product Status, 2014
  • Table 81: Patch Pump-2, Product Status, 2014
  • Table 82: Patch Pump-3, Product Status, 2014
  • Table 83: Spring Insulin Pump, Product Status, 2014
  • Table 84: Spring Zone Hybrid Patch Pump, Product Status, 2014
  • Table 85: U-Strip Insulin Patch, Product Status, 2014
  • Table 86: Exenatide Once Weekly Pen Device, Product Status, 2014
  • Table 87: Fix-Flex Device, Product Status, 2014
  • Table 88: G-Pen, Product Status, 2014
  • Table 89: G-Pen Mini, Product Status, 2014
  • Table 90: Insulin Guard Self-Injector Safety Needle, Product Status, 2014
  • Table 91: JuniorSTAR, Product Status, 2014
  • Table 92: La Fenice Pen, Product Status, 2014
  • Table 93: Levemir FlexTouch, Product Status, 2014
  • Table 94: Next Generation Pen Needle II, Product Status, 2014
  • Table 95: NovoLog FlexTouch, Product Status, 2014

List of Figures

  • Figure 1: Insulin Delivery Devices Market, Insulin Pump Timeline, 1963-2011
  • Figure 2: Insulin Delivery Devices Market, Device Overview
  • Figure 3: Insulin Delivery Devices Market, Comparison of Insulin Therapy
  • Figure 4: Insulin Delivery Devices Market, Global, Revenue ($bn), 2005-2012
  • Figure 5: Insulin Delivery Devices Market, Global, Revenue ($bn), 2012-2019
  • Figure 6: Insulin Delivery Devices Market, Global, Key Company Share by Region (%), 2012
  • Figure 7: Insulin Delivery Devices Market, Market Trends
  • Figure 8: Insulin Delivery Devices Market, Ongoing/Completed Studies on Artificial Pancreas
  • Figure 9: Insulin Delivery Devices Market, Leading Integrated CGM-Insulin Pump Brands, 2013
  • Figure 10: Insulin Delivery Devices Market, Market Dynamics
  • Figure 11: Insulin Delivery Devices Market, Number of Patients in 10 Largest Markets (Aged 29-79 Years), 2013-2035
  • Figure 12: Insulin Delivery Devices Market, Health Expenditure due to Diabetes (20-79 Years) and Diabetes Population, 2013
  • Figure 13: Insulin Delivery Devices Market, Clinical Studies Indicating Safety and Efficacy of Insulin Pumps
  • Figure 14: Insulin Delivery Devices Market, Annual Cost of Insulin Pumps and Supplies and Annual Cost of Treatment for Serious Complications in Alberta, Canada, 2012 and 2032
  • Figure 15: Insulin Delivery Devices Market, Clinical Studies Indicating Advantages of Insulin Pens Over Syringes
  • Figure 16: Insulin Delivery Devices Market, Patient Compliance Analysis for Insulin Pens and Insulin Syringes
  • Figure 17: Insulin Pens Market, Global, Revenue ($bn), 2005-2012
  • Figure 18: Insulin Pens Market, Global, Revenue Forecast ($bn), 2012-2019
  • Figure 19: Insulin Pumps Market, Global, Revenue ($m), 2005-2012
  • Figure 20: Insulin Pumps Market, Global, Revenue Forecast ($m), 2012-2019
  • Figure 21: Insulin Syringes Market, Global, Revenue ($m), 2005-2012
  • Figure 22: Insulin Syringes Market, Global, Revenue Forecast ($m), 2012-2019
  • Figure 23: Traditional Insulin Pump Accessories Market, Global, Revenue ($m), 2005-2012
  • Figure 24: Traditional Insulin Pump Accessories Market, Global, Revenue Forecast ($m), 2012-2019
  • Figure 25: Insulin Delivery Devices Market, Global, Cross-country Analysis, CAGR (%), 2005-2019
  • Figure 26: Insulin Delivery Devices Market, US, Cross-segment Analysis, CAGR (%), 2005-2019
  • Figure 27: Insulin Delivery Devices Market, US, Revenue ($bn), Volume (million), 2005-2019
  • Figure 28: Insulin Delivery Devices Market, Japan, Cross-segment Analysis, CAGR (%), 2005-2019
  • Figure 29: Insulin Delivery Devices Market, Japan, Revenue and Volume (000s), 2005-2019
  • Figure 30: Insulin Delivery Devices Market, Germany, Cross-segment Analysis, CAGR (%), 2005-2019
  • Figure 31: Insulin Delivery Devices Market, Germany, Revenue ($m), Volume ('000), 2005-2019
  • Figure 32: Insulin Delivery Devices Market, France, Cross-segment Analysis, CAGR (%), 2005-2019
  • Figure 33: Insulin Delivery Devices Market, France, Revenue ($m), Volume ('000), 2005-2019
  • Figure 34: Insulin Delivery Devices Market, UK, Cross-segment Analysis, CAGR (%), 2005-2019
  • Figure 35: Insulin Delivery Devices Market, UK, Revenue ($m), Volume ('000), 2005-2019
  • Figure 36: Insulin Delivery Devices Market, Spain, Cross-segment Analysis, CAGR (%), 2005-2019
  • Figure 37: Insulin Delivery Devices Market, Spain, Revenue ($m), Volume ('000), 2005-2019
  • Figure 38: Insulin Delivery Devices Market, Italy, Cross-segment Analysis, CAGR (%), 2005-2019
  • Figure 39: Insulin Delivery Devices Market, Italy, Revenue ($m), Volume ('000), 2005-2019
  • Figure 40: Insulin Delivery Devices Market, Canada, Cross-segment Analysis, CAGR (%), 2005-2019
  • Figure 41: Insulin Delivery Devices Market, Canada, Revenue ($m), Volume ('000), 2005-2019
  • Figure 42: Insulin Delivery Devices Market, China, Cross-segment Analysis, CAGR (%), 2005-2019
  • Figure 43: Insulin Delivery Devices Market, China, Revenue ($m), Volume ('000), 2005-2019
  • Figure 44: Insulin Delivery Devices Market, Australia, Cross-segment Analysis, CAGR (%), 2005-2019
  • Figure 45: Insulin Delivery Devices Market, Australia, Revenue ($m), Volume ('000), 2005-2019
  • Figure 46: Insulin Delivery Devices Market, India, Cross-segment Analysis, CAGR (%), 2005-2019
  • Figure 47: Insulin Delivery Devices Market, India, Revenue ($m), Volume ('0000), 2005-2019
  • Figure 48: Insulin Delivery Devices Market, Brazil, Cross-segment Analysis, CAGR (%), 2005-2019
  • Figure 49: Insulin Delivery Devices Market, Brazil, Revenue ($m), Volume ('000), 2005-2019
  • Figure 50: Insulin Delivery Devices Market, Comparison of Leading Insulin Pumps by Size and Color Options, 2014
  • Figure 51: Insulin Delivery Devices Market, Comparison of Leading Insulin Pumps by Basal and Bolus Specifications, 2014
  • Figure 52: Insulin Delivery Devices Market, Comparison of Leading Insulin Pumps by Bolus Calculator Options and Operation, 2014
  • Figure 53: Global Insulin Delivery Devices Market, Pipeline Products Summary, 2013
  • Figure 54: Global Insulin Delivery Devices Market, Deals Summary, 2013
Back to Top